EMD Serono Email Format

Pharmaceutical Manufacturing
1,001-2,500 employees
Boston, MA, USA

EMD Serono is a pharmaceutical company focused on developing treatments for difficult-to-treat conditions including infertility, multiple sclerosis, and cancer in the U.S. and Canada.

Find contacts at EMD Serono

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

first.last@emdserono.com

Company Overview

Industry
Pharmaceutical Manufacturing
Founded
1668
Headquarters
Boston, MA, USA
Revenue
$1B-$2.5B
FUNDING Stage
Subsidiary
Key Executives
Miguel Fernández Alcalde (President of EMD Serono), Lisa Walsh (Regional Controller), Dan Van Horn (Chief Operating Officer)

Tech Stack

Akamai Edge

Infrastructure

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of EMD Serono?

EMD Serono uses the first.last format, so Jane Smith would be jane.smith@emdserono.com.

What therapeutic areas does EMD Serono focus on?

EMD Serono concentrates on four therapeutic areas: Neurology and Immunology, Fertility, Oncology, and Endocrinology. Its approved portfolio includes MAVENCLAD and Rebif for relapsing multiple sclerosis, BAVENCIO for urothelial carcinoma, TEPMETKO for MET-altered lung cancer, and GONAL-f for infertility.

Who leads EMD Serono as of 2026?

Miguel Fernandez Alcalde is the President of EMD Serono, heading the North American healthcare business across the U.S. and Canada. He joined Merck KGaA in 2014 and previously served as Chief Operating Officer before stepping into the presidential role.

How has EMD Serono expanded patient access to its IVF medicines in 2026?

In 2026, EMD Serono made its full fertility medication portfolio, including GONAL-f, Ovidrel, and Cetrotide, available through TrumpRx.gov and FertilityInstantSavings.com, giving out-of-pocket patients discounted access to the company's IVF therapies in line with a federal executive order on expanding IVF access.

Can Clay help me find verified EMD Serono contacts using the first.last@emdserono.com format?

Yes, Clay can help you build a targeted list of EMD Serono professionals by enriching records with verified email addresses that follow the first.last@emdserono.com format, making it straightforward to reach the right person across divisions like oncology, fertility, or neurology and immunology.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles